دورية أكاديمية

Comparing the effects of ketotifen fumarate eye drops and ketotifen oral pills on symptom severity and quality of life in patients with allergic rhinitis: a double-blind randomized clinical trial.

التفاصيل البيبلوغرافية
العنوان: Comparing the effects of ketotifen fumarate eye drops and ketotifen oral pills on symptom severity and quality of life in patients with allergic rhinitis: a double-blind randomized clinical trial.
المؤلفون: Akhavan, Asghar, Karimi-Sari, Hamidreza, Khosravi, Mohammad Hossein, Arefzadeh, Esmaeil, Yavarahmadi, Mohammadhosein
المصدر: International Forum of Allergy and Rhinology, 5 (5), 386-91 (2015-05)
بيانات النشر: John Wiley and Sons Inc.
سنة النشر: 2015
المجموعة: University of Liège: ORBi (Open Repository and Bibliography)
مصطلحات موضوعية: allergic rhinitis, ketotifen fumarate eye drops, ketotifen pills, quality of life, symptoms, Anti-Allergic Agents, Ophthalmic Solutions, Ketotifen, Administration, Oral, Topical, Adult, Anti-Allergic Agents/administration & dosage, Double-Blind Method, Female, Humans, Ketotifen/administration & dosage, Male, Quality of Life/psychology, Rhinitis, Allergic/diagnosis, Allergic/drug therapy, Allergic/psychology, Young Adult, Allergic, Immunology and Allergy, Otorhinolaryngology, Human health sciences, Otolaryngology, Sciences de la santé humaine
الوصف: peer reviewed ; BACKGROUND: Allergic rhinitis is a chronic inflammatory disease of nasal mucosa. Previous studies have shown the therapeutic effects of ketotifen eye drops on allergic conjunctivitis and rhinitis patients. This study was designed to compare the effects of ketotifen drops and oral ketotifen pills on symptoms and quality of life in allergic rhinitis patients. METHODS: In this double-blind randomized clinical trial, patients with mild allergic rhinitis who were referred to the allergy clinic of Baqiyatallah Hospital from March to April 2014 were randomly allocated to 2 groups; the first group received ketotifen drops (1 drop every 12 hours) with placebo pills (2 pills daily), and the second group received placebo eye drops with ketotifen pills for 4 weeks. Symptoms (sneezing, runny nose, itching, and nasal obstruction) severity were examined and Rhinitis Quality of Life Questionnaire (RQLQ) scores were evaluated in the second and fourth weeks. RESULTS: A total of 140 patients were evaluated in 2 groups. The mean age was 30.33 years. There were no significant differences in demographic data between the groups (p > 0.05). Both groups showed a significant improvement in rhinorrhea, nasal congestion, nasal itching, coughing, sneezing, RQLQ, and nasal smear eosinophil percent compared to baseline amounts (p < 0.05). Improvements were significantly more in the drops group (p < 0.05). CONCLUSION: Because of the absence of systemic complications in ketotifen eye drops in patients with allergic rhinitis and their easy availability in Iran, using this medication instead of systemic therapies is suggested. Nevertheless, more studies are required to evaluate the long-term effects of using this drug and the recurrence rate of symptoms.
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 2042-6976
2042-6984
العلاقة: urn:issn:2042-6976; urn:issn:2042-6984; https://orbi.uliege.be/handle/2268/290042Test; info:hdl:2268/290042; https://orbi.uliege.be/bitstream/2268/290042/1/akhavan2015.pdfTest; scopus-id:2-s2.0-84929047995; info:pmid:25678217
DOI: 10.1002/alr.21491
الإتاحة: https://doi.org/10.1002/alr.21491Test
https://orbi.uliege.be/handle/2268/290042Test
https://orbi.uliege.be/bitstream/2268/290042/1/akhavan2015.pdfTest
حقوق: open access ; http://purl.org/coar/access_right/c_abf2Test ; info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.6A37B1D5
قاعدة البيانات: BASE
الوصف
تدمد:20426976
20426984
DOI:10.1002/alr.21491